Recent CHRS Stock Price | CHRS Stock Predictions | |
$2.15 | +287.44% |
$8.33 |
Recent CHRS Analyst Ratings Breakdown, Making CHRS Stock Predictions | ||||
---|---|---|---|---|
Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
Strong buy ratings: | 7 | 7 | 7 | 7 |
Buy ratings: | 0 | 0 | 0 | 0 |
Hold ratings: | 3 | 3 | 3 | 3 |
Sell ratings: | 0 | 0 | 0 | 0 |
Strong sell ratings: | 0 | 0 | 0 | 0 |
Average rating: | 1.6 | 1.6 | 1.6 | 1.6 |
For the CHRS stock predictions from the analysts covering Coherus BioSciences Inc, we have collected all of the individual CHRS stock predictions for stock price one year from now (i.e. each analyst's "forward price target") and at the top of this page we have presented the average prediction across the 6 different analysts covering CHRS (as reported in
data provided by Zacks Investment Research via Quandl.com).
But since CHRS stock predictions may vary widely, another useful metric to consider is the median CHRS stock prediction, which represents the price at which half of the analysts
made CHRS stock predictions that were higher and half made CHRS stock predictions that were lower. This makes for a different take on the CHRS stock predictions out there, as compared to average or mean.
And that median across all the individual CHRS stock predictions was: $8.5 as of 2024-04-18.
The very highest of the CHRS stock predictions for one year price target was $11.0, while the very lowest of the CHRS stock predictions in the analyst group was
$4.0 (with a standard deviation of $2.658). Get the latest Zacks research report on CHRS — FREE
Find out: CHRS next earnings date »
Dividend Growth Stocks: 25 Aristocrats
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Other stock predictions:
INZY Stock Predictions
JNPR Stock Predictions
BCPC Stock Predictions
PD Stock Predictions
MTG Stock Predictions
CSSE Stock Predictions
TCOM Stock Predictions
ACIW Stock Predictions
RDFN Stock Predictions
|
|
Buy (3.40 out of 4) 100th percentile
(ranked higher than approx. 100% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com |